CYCC
Price
$7.12
Change
-$0.34 (-4.56%)
Updated
Sep 5 closing price
Capitalization
15.94M
PPTDF
Price
$11.00
Change
-$0.10 (-0.90%)
Updated
Sep 5 closing price
Capitalization
1.34B
Interact to see
Advertisement

CYCC vs PPTDF

Header iconCYCC vs PPTDF Comparison
Open Charts CYCC vs PPTDFBanner chart's image
Cyclacel Pharmaceuticals
Price$7.12
Change-$0.34 (-4.56%)
Volume$82.28K
Capitalization15.94M
Peptidream
Price$11.00
Change-$0.10 (-0.90%)
Volume$1.8K
Capitalization1.34B
CYCC vs PPTDF Comparison Chart in %
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. PPTDF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a Hold and PPTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CYCC: $7.12 vs. PPTDF: $11.00)
Brand notoriety: CYCC and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 3% vs. PPTDF: 238%
Market capitalization -- CYCC: $15.94M vs. PPTDF: $1.34B
CYCC [@Biotechnology] is valued at $15.94M. PPTDF’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 0 FA rating(s) are green whilePPTDF’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 0 green, 5 red.
  • PPTDF’s FA Score: 0 green, 5 red.
According to our system of comparison, CYCC is a better buy in the long-term than PPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 3 TA indicator(s) are bullish while PPTDF’s TA Score has 4 bullish TA indicator(s).

  • CYCC’s TA Score: 3 bullish, 5 bearish.
  • PPTDF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, PPTDF is a better buy in the short-term than CYCC.

Price Growth

CYCC (@Biotechnology) experienced а -13.54% price change this week, while PPTDF (@Biotechnology) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($1.34B) has a higher market cap than CYCC($15.9M). PPTDF has higher P/E ratio than CYCC: PPTDF (14.62) vs CYCC (0.00). PPTDF YTD gains are higher at: -38.375 vs. CYCC (-92.110). CYCC has higher annual earnings (EBITDA): -10.41M vs. PPTDF (-3.66B). PPTDF has more cash in the bank: 33.3B vs. CYCC (4.28M). CYCC has less debt than PPTDF: CYCC (10K) vs PPTDF (18.3B). PPTDF has higher revenues than CYCC: PPTDF (19.1B) vs CYCC (10K).
CYCCPPTDFCYCC / PPTDF
Capitalization15.9M1.34B1%
EBITDA-10.41M-3.66B0%
Gain YTD-92.110-38.375240%
P/E Ratio0.0014.620%
Revenue10K19.1B0%
Total Cash4.28M33.3B0%
Total Debt10K18.3B0%
FUNDAMENTALS RATINGS
CYCC vs PPTDF: Fundamental Ratings
CYCC
PPTDF
OUTLOOK RATING
1..100
5850
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6585
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYCC's Valuation (82) in the Biotechnology industry is in the same range as PPTDF (88) in the null industry. This means that CYCC’s stock grew similarly to PPTDF’s over the last 12 months.

CYCC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PPTDF (100) in the null industry. This means that CYCC’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's SMR Rating (99) in the null industry is in the same range as CYCC (100) in the Biotechnology industry. This means that PPTDF’s stock grew similarly to CYCC’s over the last 12 months.

CYCC's Price Growth Rating (65) in the Biotechnology industry is in the same range as PPTDF (85) in the null industry. This means that CYCC’s stock grew similarly to PPTDF’s over the last 12 months.

CYCC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PPTDF (100) in the null industry. This means that CYCC’s stock grew similarly to PPTDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPPTDF
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
25%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
29%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
21%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
29%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
45%
Advances
ODDS (%)
Bullish Trend 27 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
27%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
33%
View a ticker or compare two or three
Interact to see
Advertisement
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNVR22.900.31
+1.37%
Hanover Bancorp
CCNE26.05-0.26
-0.99%
CNB Financial Corp
FRSH12.84-0.17
-1.31%
Freshworks
MTB199.57-2.79
-1.38%
M&T Bank Corp
DTSS2.04-0.03
-1.63%
Datasea

CYCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCC has been loosely correlated with MIRM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCC jumps, then MIRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
-4.56%
MIRM - CYCC
36%
Loosely correlated
+2.53%
ORMP - CYCC
30%
Poorly correlated
+0.45%
IMMP - CYCC
27%
Poorly correlated
+1.85%
RNAC - CYCC
26%
Poorly correlated
+6.40%
ICCC - CYCC
26%
Poorly correlated
-2.91%
More

PPTDF and

Correlation & Price change

A.I.dvisor tells us that PPTDF and HOTH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPTDF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
-0.90%
HOTH - PPTDF
31%
Poorly correlated
-0.75%
CYCC - PPTDF
28%
Poorly correlated
-4.56%
IGC - PPTDF
22%
Poorly correlated
-0.98%
LABFF - PPTDF
22%
Poorly correlated
N/A
CPMV - PPTDF
21%
Poorly correlated
+97.20%
More